A detailed history of State Of Wyoming transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Of Wyoming holds 10,377 shares of HALO stock, worth $547,905. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,377
Previous 9,244 12.26%
Holding current value
$547,905
Previous $484,000 22.52%
% of portfolio
0.09%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.3 - $64.42 $58,122 - $72,987
1,133 Added 12.26%
10,377 $593,000
Q2 2024

Aug 14, 2024

SELL
$37.81 - $52.4 $273,782 - $379,428
-7,241 Reduced 43.92%
9,244 $484,000
Q1 2024

May 13, 2024

BUY
$33.68 - $41.95 $190,325 - $237,059
5,651 Added 52.16%
16,485 $670,000
Q4 2023

Feb 14, 2024

BUY
$33.32 - $42.1 $59,842 - $75,611
1,796 Added 19.87%
10,834 $400,000
Q3 2023

Nov 14, 2023

BUY
$36.46 - $44.03 $33,761 - $40,771
926 Added 11.42%
9,038 $345,000
Q2 2023

Aug 14, 2023

BUY
$30.28 - $38.74 $137,410 - $175,802
4,538 Added 126.97%
8,112 $292,000
Q1 2023

May 12, 2023

SELL
$32.86 - $55.7 $12,881 - $21,834
-392 Reduced 9.88%
3,574 $136,000
Q4 2022

Feb 14, 2023

SELL
$40.06 - $59.44 $10,415 - $15,454
-260 Reduced 6.15%
3,966 $225,000
Q3 2022

Nov 14, 2022

SELL
$38.53 - $51.78 $6,973 - $9,372
-181 Reduced 4.11%
4,226 $167,000
Q2 2022

Aug 15, 2022

SELL
$37.35 - $48.3 $143,760 - $185,906
-3,849 Reduced 46.62%
4,407 $194,000
Q1 2022

May 13, 2022

SELL
$31.97 - $41.06 $66,018 - $84,788
-2,065 Reduced 20.01%
8,256 $329,000
Q4 2021

Feb 11, 2022

BUY
$31.82 - $40.75 $67,012 - $85,819
2,106 Added 25.64%
10,321 $415,000
Q3 2021

Feb 14, 2022

BUY
$38.47 - $46.42 $61,282 - $73,947
1,593 Added 24.06%
8,215 $334,000
Q3 2021

Feb 11, 2022

BUY
$38.47 - $46.42 $16,234 - $19,589
422 Added 6.81%
6,622 $269,000
Q2 2021

Feb 14, 2022

BUY
$38.84 - $51.31 $36,354 - $48,026
936 Added 17.78%
6,200 $282,000
Q2 2021

Feb 11, 2022

BUY
$38.84 - $51.31 $204,453 - $270,095
5,264 New
5,264 $239,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.35B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.